 |
| copyright Sauligno via Creative Commons |
CANCER DIGEST – Aug. 7, 2014 – In the first review of all the available evidence from many studies and clinical trials of preventive aspirin use, researchers found that taking aspirin for 10 years could cut bowel cancer cases by around 35 percent and deaths by 40 percent.
Led by Jack Cuzick, head of Queen Mary University of London’s Centre for Cancer Prevention, the researchers also found the rates of esophageal and stomach cancers were cut by 30 percent and deaths from these cancers by 35-50 percent. The study was published today in the journal Annals of Oncology.
The evidence shows people need to start taking a daily dose of 75-100 mg for at least five years and probably 10 years between the ages of 50 and 65. However, the research also warns that taking aspirin long-term increases the risk of bleeding from the digestive tract, e.g. stomach bleeding. Overall, rates of serious or fatal gastrointestinal bleeding are very low under the age of 70, but increased sharply after that age. The risk of bleeding depends on a number of known factors, which people need to be aware of before starting regular aspirin and should consult with a doctor before embarking on daily medication.
No comments:
Post a Comment